Allergan Inc said on Monday the U.S. Food and Drug Administration had raised issues about its application for a new acute migraine aerosol but had separately approved a treatment for diabetic macular edema.Allergan, the Botox maker that is fighting off a hostile bid from Valeant Pharmaceuticals International Inc, said the FDA had approved its Ozurdex sustained-release biodegradable steroid implant as a new treatment option for some patients with diabetic macular edema.The FDA approved Ozurdex for use in adult patients who have an artificial lens implant or who are scheduled for cataract surgery, Allergan said.Allergan did not receive approval for Semprana, formerly known as Levadex. It said it had received a second "complete response letter" from the agency and now expected the next action from the FDA to occur in the second quarter of 2015.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 1.52% or $-2.65/share to $171.30. In the past year, the shares have traded as low as $82.56 and as high as $173.96. On average, 4527360 shares of AGN exchange hands on a given day and today's volume is recorded at 314835.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.87% or $-1.12/share to $127.73. In the past year, the shares have traded as low as $86.89 and as high as $153.10. On average, 3697400 shares of VRX exchange hands on a given day and today's volume is recorded at 375452.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 1.22% or $-1.68/share to $136.44. In the past year, the shares have traded as low as $89.35 and as high as $170.45. On average, 397017 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 32728.
Source
